• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4835299)   Today's Articles (33)
For: Selzner N, Chen L, Borozan I, Edwards A, Heathcote EJ, McGilvray I. Hepatic gene expression and prediction of therapy response in chronic hepatitis C patients. J Hepatol 2008;48:708-13. [PMID: 18329749 DOI: 10.1016/j.jhep.2008.02.010] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Number Cited by Other Article(s)
1
Serum level of interleukin-8 and interleukin-10 as predictors for response to interferon–ribavirin combined therapy. EGYPTIAN LIVER JOURNAL 2016. [DOI: 10.1097/01.elx.0000481902.94221.61] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]  Open
2
Faisal N, Mumtaz K, Marquez M, Renner EL, Lilly LB. High sustained virological response to pegylated interferon and ribavirin for recurrent genotype 3 hepatitis C infection post-liver transplantation. Hepatol Int 2014;9:76-83. [PMID: 25788382 DOI: 10.1007/s12072-014-9589-6] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/04/2014] [Accepted: 10/20/2014] [Indexed: 12/17/2022]
3
Li Y, Li S, Duan X, Liu B, Yang C, Zeng P, McGilvray I, Chen L. Activation of endogenous type I IFN signaling contributes to persistent HCV infection. Rev Med Virol 2014;24:332-42. [PMID: 24806972 DOI: 10.1002/rmv.1795] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2014] [Revised: 04/04/2014] [Accepted: 04/04/2014] [Indexed: 12/14/2022]
4
Shaker OG, Sadik NAH. Polymorphisms in interleukin-10 and interleukin-28B genes in Egyptian patients with chronic hepatitis C virus genotype 4 and their effect on the response to pegylated interferon/ribavirin-therapy. J Gastroenterol Hepatol 2012;27:1842-9. [PMID: 23020144 DOI: 10.1111/j.1440-1746.2012.07273.x] [Citation(s) in RCA: 41] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 07/26/2012] [Indexed: 12/13/2022]
5
Rahman W, Huang P, Belov L, Chrisp JS, Christopherson RI, Stapelberg PM, Warner FJ, George J, Bowen DG, Strasser SI, Koorey D, Sharland AF, McCaughan GW, Shackel NA. Analysis of human liver disease using a cluster of differentiation (CD) antibody microarray. Liver Int 2012;32:1527-34. [PMID: 22863037 DOI: 10.1111/j.1478-3231.2012.02854.x] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/14/2012] [Revised: 06/17/2012] [Accepted: 06/27/2012] [Indexed: 02/13/2023]
6
François C, Coulouarn C, Descamps V, Castelain S, Brochot E, Baron A, Duchaussoy I, Capron D, Nguyen-Khac E, Duverlie G. The treatment response of chronically hepatitis C virus-infected patients depends on interferon concentration but not on interferon gene expression in peripheral blood mononuclear cells. Antimicrob Agents Chemother 2012;56:903-908. [PMID: 22123700 PMCID: PMC3264224 DOI: 10.1128/aac.05646-11] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2011] [Accepted: 11/18/2011] [Indexed: 01/09/2023]  Open
7
Viganò M, Lampertico P, Colombo M. Drug safety evaluation of adefovir in HBV infection. Expert Opin Drug Saf 2011;10:809-18. [PMID: 21671843 DOI: 10.1517/14740338.2011.593507] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
8
Shalev I, Selzner N, Helmy A, Foerster K, Adeyi OA, Grant DR, Levy G. The Role of FGL2 in the Pathogenesis and Treatment of Hepatitis C Virus Infection. Rambam Maimonides Med J 2010;1:e0004. [PMID: 23908776 PMCID: PMC3721661 DOI: 10.5041/rmmj.10004] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]  Open
9
Duffield DS, Cai L, Kim S. Simultaneous determination of multiple mRNA levels utilizing MALDI-TOF mass spectrometry and biotinylated dideoxynucleotides. RNA (NEW YORK, N.Y.) 2010;16:1285-1291. [PMID: 20410241 PMCID: PMC2874180 DOI: 10.1261/rna.1859810] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/11/2009] [Accepted: 02/18/2010] [Indexed: 05/29/2023]
10
Chen L, Borozan I, Sun J, Guindi M, Fischer S, Feld J, Anand N, Heathcote J, Edwards AM, McGilvray ID. Cell-type specific gene expression signature in liver underlies response to interferon therapy in chronic hepatitis C infection. Gastroenterology 2010;138:1123-33.e1-3. [PMID: 19900446 DOI: 10.1053/j.gastro.2009.10.046] [Citation(s) in RCA: 87] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/28/2009] [Revised: 10/01/2009] [Accepted: 10/29/2009] [Indexed: 02/06/2023]
11
Antiviral treatment of recurrent hepatitis C after liver transplantation: predictors of response and long-term outcome. Transplantation 2010;88:1214-21. [PMID: 19935376 DOI: 10.1097/tp.0b013e3181bd783c] [Citation(s) in RCA: 107] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
12
Dieterich DT, Rizzetto M, Manns MP. Management of chronic hepatitis C patients who have relapsed or not responded to pegylated interferon alfa plus ribavirin. J Viral Hepat 2009;16:833-43. [PMID: 19889142 DOI: 10.1111/j.1365-2893.2009.01218.x] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
13
Abbas OM, Abdel-Rahman MH, Omar NA, Badran HM, Amir EM. Interleukin-10 promoter polymorphisms in hepatitis C patients with and without Schistosoma mansoni co-infection. Liver Int 2009;29:1422-30. [PMID: 19555400 DOI: 10.1111/j.1478-3231.2009.02068.x] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
14
Selzner N, McGilvray I. Can genetic variations predict HCV treatment outcomes? J Hepatol 2008;49:494-7. [PMID: 18692270 DOI: 10.1016/j.jhep.2008.07.006] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
15
Papatheodoridis GV, Paraskevis D. Role of genetic polymorphisms in the progression of liver fibrosis in chronic hepatitis C virus infection. Liver Int 2008;28:764-6. [PMID: 18647140 DOI: 10.1111/j.1478-3231.2008.01800.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/13/2023]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA